These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 26788915)

  • 1. Prostaglandin E-Major Urinary Metabolite as a Biomarker for Inflammation in Ulcerative Colitis: Prostaglandins Revisited.
    Arai Y; Matsuura T; Matsuura M; Fujiwara M; Okayasu I; Ito S; Arihiro S
    Digestion; 2016; 93(1):32-9. PubMed ID: 26788915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostaglandin E-major Urinary Metabolite as a Biomarker for Pediatric Ulcerative Colitis Activity.
    Hagiwara SI; Okayasu I; Fujiwara M; Matsuura M; Ohnishi H; Ito S; Kishimoto H; Nambu R; Kagimoto S
    J Pediatr Gastroenterol Nutr; 2017 Jun; 64(6):955-961. PubMed ID: 27906804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostaglandin E-major urinary metabolite as a reliable surrogate marker for mucosal inflammation in ulcerative colitis.
    Arai Y; Arihiro S; Matsuura T; Kato T; Matsuoka M; Saruta M; Mitsunaga M; Matsuura M; Fujiwara M; Okayasu I; Ito S; Tajiri H
    Inflamm Bowel Dis; 2014 Jul; 20(7):1208-16. PubMed ID: 24846719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostaglandin E-Major Urinary Metabolite Predicts Relapse in Patients With Ulcerative Colitis in Clinical Remission.
    Ishida N; Sugiura K; Miyazu T; Tamura S; Suzuki S; Tani S; Yamade M; Iwaizumi M; Hamaya Y; Osawa S; Furuta T; Sugimoto K
    Clin Transl Gastroenterol; 2020 Dec; 11(12):e00289. PubMed ID: 33512810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostaglandin E-major urinary metabolite diagnoses mucosal healing in patients with ulcerative colitis in remission phase.
    Sakurai T; Akita Y; Miyashita H; Miyazaki R; Maruyama Y; Saito T; Shimada M; Yamasaki T; Arhihiro S; Kato T; Matsuura T; Ikegami M; Okayasu I; Saruta M
    J Gastroenterol Hepatol; 2022 May; 37(5):847-854. PubMed ID: 35064604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significant increase in prostaglandin E-main urinary metabolite by laxative administration: comparison with ulcerative colitis.
    Fujiwara M; Okayasu I; Oritsu M; Komatsu J; Yoshitsugu M; Katoh Y; Bandoh T; Toyoshima H; Kase Y; Sugihara K; Kanno J; Hayashi Y
    Digestion; 2000; 61(3):201-6. PubMed ID: 10773726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostaglandin E-major urinary metabolite versus fecal immunochemical occult blood test as a biomarker for patient with ulcerative colitis.
    Ishida N; Miyazu T; Takano R; Tamura S; Tani S; Kagami T; Yamade M; Hamaya Y; Iwaizumi M; Osawa S; Furuta T; Miyajima H; Sugimoto K
    BMC Gastroenterol; 2020 Apr; 20(1):114. PubMed ID: 32306914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical relevance of endoscopic assessment of inflammation in ulcerative colitis: Can endoscopic evaluation predict outcomes?
    Mohammed N; Subramanian V
    World J Gastroenterol; 2016 Nov; 22(42):9324-9332. PubMed ID: 27895420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Confocal laser endomicroscopy: a new gold standard for the assessment of mucosal healing in ulcerative colitis.
    Macé V; Ahluwalia A; Coron E; Le Rhun M; Boureille A; Bossard C; Mosnier JF; Matysiak-Budnik T; Tarnawski AS
    J Gastroenterol Hepatol; 2015 Mar; 30 Suppl 1():85-92. PubMed ID: 25827810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endoscopic and clinical variables that predict sustained remission in children with ulcerative colitis treated with infliximab.
    Turner D; Griffiths AM; Veerman G; Johanns J; Damaraju L; Blank M; Hyams J
    Clin Gastroenterol Hepatol; 2013 Nov; 11(11):1460-5. PubMed ID: 23672831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histological healing after infliximab induction therapy in children with ulcerative colitis.
    Wiernicka A; Szymanska S; Cielecka-Kuszyk J; Dadalski M; Kierkus J
    World J Gastroenterol; 2015 Oct; 21(37):10654-61. PubMed ID: 26457025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endomicroscopy for assessing mucosal healing in patients with ulcerative colitis.
    Gheorghe C; Cotruta B; Iacob R; Becheanu G; Dumbrava M; Gheorghe L
    J Gastrointestin Liver Dis; 2011 Dec; 20(4):423-6. PubMed ID: 22187709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mucosal immune environment in colonic carcinogenesis: CD80 expression is associated to oxidative DNA damage and TLR4-NFκB signalling.
    Scarpa M; Cardin R; Bortolami M; Kotsafti A; Scarpa MC; Pozza A; Maran G; Picciocchi M; Ruffolo C; D'Incà R; Sturniolo GC; Castagliuolo I; Castoro C; Angriman I
    Eur J Cancer; 2013 Jan; 49(1):254-63. PubMed ID: 22704122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of ulcerative colitis and its associated colorectal neoplasia as a model of the organ-specific chronic inflammation-carcinoma sequence.
    Okayasu I
    Pathol Int; 2012 Jun; 62(6):368-80. PubMed ID: 22612505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential activation of total and EGF receptor (EGF-R) tyrosine kinase (tyr-k) in the rectal mucosa in patients with adenomatous polyps, ulcerative colitis and colon cancer.
    Malecka-Panas E; Kordek R; Biernat W; Tureaud J; Liberski PP; Majumdar AP
    Hepatogastroenterology; 1997; 44(14):435-40. PubMed ID: 9164515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum human trefoil factor 3 is a biomarker for mucosal healing in ulcerative colitis patients with minimal disease activity.
    Srivastava S; Kedia S; Kumar S; Pratap Mouli V; Dhingra R; Sachdev V; Tiwari V; Kurrey L; Pradhan R; Ahuja V
    J Crohns Colitis; 2015 Jul; 9(7):575-9. PubMed ID: 25964429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histologic remission: the ultimate therapeutic goal in ulcerative colitis?
    Peyrin-Biroulet L; Bressenot A; Kampman W
    Clin Gastroenterol Hepatol; 2014 Jun; 12(6):929-34.e2. PubMed ID: 23911875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of mucosal healing of ulcerative colitis by a quantitative fecal immunochemical test.
    Nakarai A; Kato J; Hiraoka S; Kuriyama M; Akita M; Hirakawa T; Okada H; Yamamoto K
    Am J Gastroenterol; 2013 Jan; 108(1):83-9. PubMed ID: 23007005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endoscopic screening for dysplasia and mucosal aneuploidy in adolescents and young adults with childhood onset colitis.
    Markowitz J; McKinley M; Kahn E; Stiel L; Rosa J; Grancher K; Daum F
    Am J Gastroenterol; 1997 Nov; 92(11):2001-6. PubMed ID: 9362180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Changes in the number of neuroprotective transmitter containing mucosal nerve fibres in children with ulcerative colitis].
    Kamińska B; Landowski P; Gonkowski S; Majewski M; Renke J; Korzon M
    Med Wieku Rozwoj; 2006; 10(2):483-91. PubMed ID: 16825719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.